While the deal makes strategic sense, integrating two distinct businesses and delivering profitability ahead of a potential ...

India's bioeconomy has experienced significant growth, increasing from USD 166 billion in 2024 to USD 195 billion in 2025. This expansion is driven by diverse industries including biopharmaceuticals ...

The Minister credited BIRAC as a key catalyst in translating scientific research into commercially viable products.

Discover how CRISPR genome editing is revolutionizing medicine. Learn the science of Cas9, current clinical trials, and the future of gene editing.